Kathirvel E et al. |
Acetyl-L-carnitine and lipoic acid improve mitochondrial abnormalities and serum levels of liver enzymes in a mouse model of nonalcoholic fatty liver disease. |
2013 |
Nutr Res |
pmid:24176233
|
Morand R et al. |
Quantification of plasma carnitine and acylcarnitines by high-performance liquid chromatography-tandem mass spectrometry using online solid-phase extraction. |
2013 |
Anal Bioanal Chem |
pmid:23995505
|
Babicová A et al. |
In vivo study of radioprotective effect of NO-synthase inhibitors and acetyl-L-carnitine. |
2013 |
Physiol Res |
pmid:23869893
|
Hershman DL et al. |
Randomized double-blind placebo-controlled trial of acetyl-L-carnitine for the prevention of taxane-induced neuropathy in women undergoing adjuvant breast cancer therapy. |
2013 |
J. Clin. Oncol. |
pmid:23733756
|
Cuccurazzu B et al. |
Upregulation of mGlu2 receptors via NF-κB p65 acetylation is involved in the Proneurogenic and antidepressant effects of acetyl-L-carnitine. |
2013 |
Neuropsychopharmacology |
pmid:23670591
|
Ryckman KK et al. |
The influence of maternal disease on metabolites measured as part of newborn screening. |
2013 |
J. Matern. Fetal. Neonatal. Med. |
pmid:23550828
|
Hanada H et al. |
Acetyl-L-carnitine suppresses thyroid hormone-induced and spontaneous anuran tadpole tail shortening. |
2013 |
Hereditas |
pmid:23489246
|
Russo SJ and Charney DS |
Next generation antidepressants. |
2013 |
Proc. Natl. Acad. Sci. U.S.A. |
pmid:23471996
|
Lodi A et al. |
Proton NMR-based metabolite analyses of archived serial paired serum and urine samples from myeloma patients at different stages of disease activity identifies acetylcarnitine as a novel marker of active disease. |
2013 |
PLoS ONE |
pmid:23431376
|
Zuena AR et al. |
Transplacental exposure to AZT induces adverse neurochemical and behavioral effects in a mouse model: protection by L-acetylcarnitine. |
2013 |
PLoS ONE |
pmid:23409035
|